Clinical Trials Directory

Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients With Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

The purpose of this trial is to study how well pemetrexed disodium or observation works in treating patients with malignant pleural mesothelioma without progressive disease after first-line chemotherapy. Pemetrexed disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Stanford is now accepting new patients for this trial.

Investigator(s):

Intervention(s):

  • drug : pemetrexed disodium
  • other : clinical observation

Phase: Phase 2

Eligibility

Ages Eligible For Study:

18 Years - N/A

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ekaterina Dib
650-723-0503
Recruiting

Footer Links: